Publikationen, an denen er mitarbeitet Miguel Ángel Álvarez de Mon González (37)

2023

  1. A Review: Integrative Perspectives on the Features and Clinical Management of Psychotic Episodes in Pregnancy

    Journal of Clinical Medicine, Vol. 12, Núm. 2

  2. A comprehensive look at the psychoneuroimmunoendocrinology of spinal cord injury and its progression: mechanisms and clinical opportunities

    Military Medical Research, Vol. 10, Núm. 1

  3. Evidence of Increased Oxidative Stress in the Placental Tissue of Women Who Suffered an Episode of Psychosis during Pregnancy

    Antioxidants, Vol. 12, Núm. 1

  4. Exploring Perceptions About Paracetamol, Tramadol, and Codeine on Twitter Using Machine Learning: Quantitative and Qualitative Observational Study

    Journal of medical Internet research, Vol. 25, pp. e45660

  5. Microbiota–gut–brain axis mechanisms in the complex network of bipolar disorders: potential clinical implications and translational opportunities

    Molecular Psychiatry, Vol. 28, Núm. 7, pp. 2645-2673

  6. The Placentas of Women Who Suffer an Episode of Psychosis during Pregnancy Have Increased Lipid Peroxidation with Evidence of Ferroptosis

    Biomolecules, Vol. 13, Núm. 1

  7. Updated Views in Targeted Therapy in the Patient with Non-Small Cell Lung Cancer

    Journal of Personalized Medicine, Vol. 13, Núm. 2

  8. Using Twitter Data Analysis to Understand the Perceptions, Beliefs, and Attitudes about Pharmacotherapy Used in Rheumatology: An Observational Study

    Healthcare (Switzerland), Vol. 11, Núm. 11

  9. Women with psychotic episodes during pregnancy show increased markers of placental damage with Tenney-Parker changes

    Histology and Histopathology, Vol. 38, Núm. 10, pp. 1109-1118

2022

  1. An Updated View of the Importance of Vesicular Trafficking and Transport and Their Role in Immune-Mediated Diseases: Potential Therapeutic Interventions

    Membranes, Vol. 12, Núm. 6

  2. Biological Role of Nutrients, Food and Dietary Patterns in the Prevention and Clinical Management of Major Depressive Disorder

    Nutrients, Vol. 14, Núm. 15

  3. Clinical Applications of Classical and Novel Biological Markers of Pancreatic Cancer

    Cancers, Vol. 14, Núm. 8

  4. Contribution of the Elastic Component and Venous Wall Arterialization in Patients with Venous Reflux

    Journal of Personalized Medicine, Vol. 12, Núm. 2

  5. Differential malondialdehyde (MDA) detection in plasma samples of patients with major depressive disorder (MDD): A potential biomarker

    Journal of International Medical Research, Vol. 50, Núm. 5

  6. Gut Microbiota Metabolites in Major Depressive Disorder—Deep Insights into Their Pathophysiological Role and Potential Translational Applications

    Metabolites, Vol. 12, Núm. 1

  7. Immune-Mediated Diseases from the Point of View of Psychoneuroimmunoendocrinology

    Biology, Vol. 11, Núm. 7

  8. Implication of ERBB2 as a Predictive Tool for Survival in Patients with Pancreatic Cancer in Histological Studies

    Current Oncology, Vol. 29, Núm. 4, pp. 2442-2453

  9. Nutrition, Epigenetics, and Major Depressive Disorder: Understanding the Connection

    Frontiers in Nutrition, Vol. 9

  10. Prognostic role of IRS-4 in the survival of patients with pancreatic cancer

    Histology and histopathology, Vol. 37, Núm. 5, pp. 449-459

  11. Understanding the basis of major depressive disorder in oncological patients: Biological links, clinical management, challenges, and lifestyle medicine

    Frontiers in Oncology, Vol. 12